High Priority Clinical Trials at the Prostate Center
Contact the Lombardi CancerLine to learn more about clinical trials available at the Prostate Center. Phone: 202-444-4000 Email: LombardiCancerLine@gunet.georgetown.edu
- Intermittent Androgen Deprivation In Patients With Stage D2 Prostate Cancer
- Open Label, Single Arm Trial Of Immunotherapy With Autologous Antigen Presenting Cells
- Phase 3 Study Evaluating DN-101 In Combination With Docetaxel in Androgen-Independent Prostate Cancer
- Phase 3 Study Of Early Versus Standard Zoledronic Acid To Prevent Skeletal Related Events
- Phase 3 Trial Comparing Docetaxel and Prednisone With and Without Bevacizumab (Avastin)
- Phase 3 Trial Of Immunotherapy With Autologous Antigen Presenting Cells